Genmab A/S
NASDAQ:GMAB
Wall Street
Price Targets
GMAB Price Targets Summary
Genmab A/S
According to Wall Street analysts, the average 1-year price target for
GMAB
is 47.44 USD
with a low forecast of 16.35 USD and a high forecast of 172.82 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is GMAB's stock price target?
Price Target
47.44
USD
According to Wall Street analysts, the average 1-year price target for
GMAB
is 47.44 USD
with a low forecast of 16.35 USD and a high forecast of 172.82 USD.
What is Genmab A/S's Revenue forecast?
Projected CAGR
16%
For the last 13 years the
compound annual growth rate for
Genmab A/S's revenue is
35%.
The projected
CAGR
for the next 4 years is
16%.
What is Genmab A/S's Operating Income forecast?
Projected CAGR
24%
The
compound annual growth rate
of Genmab A/S's operating income for the next 4 years is
24%.
What is Genmab A/S's Net Income forecast?
Projected CAGR
15%
The
compound annual growth rate
of Genmab A/S's net income for the next 4 years is
15%.
